|
Board of Scientific Counselors, CDC''s National Center for Injury Prevention and Control
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIA
|
An NIA representative serves on the Board of Scientific Counselor''s for the Centers for Disease Control and Prevention''s (CDC) National Center for Injury Prevention and Control. The NIA representative brings expertise in research on older adults.
|
|
Body Mass and Mortality Relationships
|
Research Initiative
|
CDC
|
NCI
|
A study of the relationships between categories of body mass and mortality in the U.S. population.
|
|
Botulism Clinical Guidance Development Working Group
|
Other
|
CDC, FDA, OS
|
NIAID
|
Review current guidelines and establish new guidance for clinical management of Botulism/Botulinum intoxication in a mass casualty incident including addressing gaps in the medical literature for mass casualty medical management of injury or disease resulting from a National Security incident for which there are medical countermeasures available in the Strategic National Stockpile intended to prevent, mitigate, or treat the injury or disease.
|
|
Brain Attack Coalition
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NINDS
|
The Brain Attack Coalition (BAC) is a group of public and private entities representing medical, scientific, advocacy, and government professionals from across the stroke continuum. The BAC is dedicated to setting direction, advancing knowledge, and communicating best practices to improve our ability to prevent and combat stroke.
|
|
BRAIN Initiative
|
Research Initiative
|
FDA
|
NINDS, NCCAM, NIA, NIBIB, NIDA, NIDCD, NIMH
|
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is part of a new Presidential focus aimed at revolutionizing our understanding of the human brain. By accelerating the development and application of innovative technologies, researchers will be able to produce a revolutionary new dynamic picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Long desired by researchers seeking new ways to treat, cure, and even prevent brain disorders, this picture will fill major gaps in our current knowledge and provide unprecedented opportunities for exploring exactly how the brain enables the human body to record, process, utilize, store, and retrieve vast quantities of information, all at the speed of thought.
|
|
Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG) Special Interest Group
|
Other
|
FDA, OSG
|
NICHD, NCI, NIDDK, OD/DPCPSI/ORWH
|
In August 2012, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) formed a trans-U.S. Department of Health and Human Services (HHS) scientific interest group, Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG), to provide an intellectual platform for the scientists from HHS agencies interested in breastfeeding and human lactation research activities.
|
|
Burkholderia Interagency Working Group
|
Other
|
OS
|
NIAID
|
This interagency working group coordinates activities related to the Burkholderia research portfolios of NIAID, BARDA and Defense Threat Reduction Agency, and shares data related to the regulatory pathway of existing and novel medical countermeasures against melioidosis and glanders.
|
|
C3 Healthcare Summit
|
Meeting/ Workshop
|
CDC
|
NIDCD
|
The C3 (Community, Collaboration, Commerce) Healthcare Summit will assemble business leaders, policy makers, educators and medical professionals to uncover and promote both U.S. and Arab world initiatives that are focused on healthcare improvements.
|
|
Cancer and Women''s Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
This formal agreement (MOU) establishes the framework and procedures to enhance collaborations and exchange of information between the FDA’s Office of Women’s Health (OWH) and the NCI’s Center to Reduce Cancer Health Disparities (CRCHD). Working together, FDA and NCI seek to increase scientific knowledge and understanding of cancer in women through targeted basic, clinical, bio-behavioral, translational, and community-based participatory research approaches/efforts. FDA and NCI both recognize the need for a unified approach to advancing scientific knowledge related to cancer and women’s health. This harmonized approach will aid in advancing the public health of all women through innovation in cancer research and medical therapies.
|
|
Cancer Control Plan, Link, Act, Network with Evidence-Based Tools (P.L.A.N.E.T)
|
Resource Development
|
AHRQ, CDC, SAMHSA
|
NCI
|
Cancer control planners, program staff, and researchers have the same goals: to reduce cancer risk, the number of new cancer cases, and the number of deaths from cancer, as well as enhance the quality of life for cancer survivors. While many share the same goals, all do not have easy access to resources that can facilitate the transfer of evidence-based research findings into practice. This Cancer Control P.L.A.N.E.T. (Plan, Link, Act, Network with Evidence-based Tools) portal provides access to data and resources that can help planners, program staff, and researchers to design, implement and evaluate evidence-based cancer control programs.
|